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1. Introduction 
Molecular imaging (MI) comprises non-invasive monitoring of functional and 
spatiotemporal processes at molecular and cellular levels in humans and other living 
systems. In contrast to conventional diagnostic imaging, MI seeks to probe the molecular 
abnormalities that are the basis of disease rather than capture the images of the end effects 
of the molecular alterations. Imaging techniques such as magnetic resonance imaging (MRI), 
single photon emission computed tomography (SPECT), positron emission tomography 
(PET) and optical fluorescence imaging (OI) have been used to monitor such processes. 
Radionuclide-based imaging methods, such as SPECT and PET, use internal radiation that is 
administered through a target-specific molecule labeled with a radionuclide at doses free of 
pharmacologic side effects. Nuclear imaging is an established clinical MI modality that, 
compared to other modalities, offers better sensitivity and has no tissue penetration limits 
(Massoud & Gamghir, 2003; Ferro-Flores et. al., 2010a). Nuclear technologies have been 
evolving toward greater sensitivity due to enhanced hardware development, such as multi-
pinhole acquisitions methods or pixelated semiconductor detectors. In parallel with the 
hardware advances, steady progress is being made in image-processing algorithms, and 
such algorithms may soon provide substantial reduction in SPECT acquisition times without 
sacrificing diagnostic quality (Madsen, 2007). The fusion of nuclear and anatomical images 
from computed tomography (CT) into a single imaging device (SPECT/CT and PET/CT) 
has been very useful for clinical oncology (Hong et al., 2009a). 
According to the American Society for Testing and Materials (ASTM), the term 
nanoparticles describes a sub-classification of ultra-fine solids with dimensions from 1 nm to 
100 nm and novel properties that distinguish them from the bulk material (ASTM, 2006). 
Nanoparticles produce multivalent effects due to multiple simultaneous interactions 
between the biomolecules conjugated to the nanoparticle surface and specific receptors for 
those biomolecules on the cell surface (Montet et al., 2006). Nanoparticles can be near 
infrared (NIR)-fluorescent (e.g. nanocrystals or quantum dots) or can have magnetic 
properties (e.g. iron oxide nanoparticles).  
Therefore, the first aim during the development of radiolabeled nanoparticles is to 
maximize the binding affinity via multimeric receptor-specific biomolecules based on the 
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multivalency principle. Large numbers of antibodies, peptides or any molecule with 
biological activity can be linked to the surface of a single radiolabeled nanocrystal (quantum 
dot), metal nanoparticle (iron oxide and gold) or single-walled carbon nanotube (SWNT) to 
improve imaging of tumors over-expressing those specific antigens or receptors. 
In general, different imaging techniques are complementary rather than competitive. 
Consequently, the second aim of engineering radiolabeled nanoparticles is to develop dual-
labeled imaging agents that target the same ligand. This allows for cross validation between 
nuclear and fluorescence optical images, MRI and nuclear images, or trimodal nuclear-MRI-
fluorescence images. 
The third aim is related to therapeutic properties. Gold nanoparticles and SWNT, which are 
designed to absorb in the NIR spectrum, cause irreversible thermal cellular destruction 
when they are irradiated using a laser (NIR light). It is important to remember that “the 
magic bullet does not exist” when it comes to cancer therapy; therefore, increasing the 
therapeutic response requires the application of combined modalities with multiple 
therapeutic agents. For example, gold nanoparticles or SWNT radiolabeled with beta-
particle emitters could represent a unique, multifunctional and target-specific 
pharmaceutical that could be administered as a single drug. This pharmaceutical would be 
capable of functioning, simultaneously, as both a targeted radiotherapy system and a 
photothermal therapy system.  
This chapter covers recent major advancements in design, synthesis, physicochemical 
characterization and molecular recognition assessment of radiolabeled synthetic 
nanoparticles for molecular imaging and highlights the therapeutic possibilities of these 
nanosystems. 
2. General aspects of radiolabeled nanoparticles 
Multivalent interactions regulate a wide variety of cellular processes, such as cell surface 
recognition events that involve inflammation and tumor metastasis. Multivalency is a 
design principle by which organized arrays amplify the strength of a binding process, e.g. 
the binding of multimeric peptides to specific receptors on a cell surface (Ocampo-Garcia et 
al., 2011a). 
Nanoparticles can be design as multimeric systems to produce multivalent effects. The 
physical and chemical properties of nanoparticles play an important role in determining 
particle-cell interactions, cellular trafficking mechanisms, biodistribution, pharmacokinetics 
and optical properties. Important nanoparticle properties include chemical composition of 
the core, size, shape, surface charge and surface chemistry.  
The synthesis of nanoparticles with a variety of physicochemical properties has led to 
important advances. Among these, gold nanoparticles are of particular importance to 
SPECT/CT or PET/CT molecular imaging due to the relative ease of surface modification 
and radiolabeling, their biocompatibility, resistance to oxidation and extraordinary optical 
properties (Giljohann et al., 2010).  
Nanoparticles of semiconductors are densely packed inorganic fluorescent semiconductor 
crystals with excellent optical properties, and these can be radiolabeled for PET/NIR 
imaging (Erathodiyil & Ying, 2011).  
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Radiolabeled iron oxide nanoparticles have been designed for use in SPECT/MRI and 
PET/MRI dual techniques (Torres et al., 2011; Jarret et al., 2008). Other radiolabeled 
nanosystems have also been proposed for biomedical applications, and these include single 
wall carbon nanotubes (Hong et al., 2009b), fullerenes (Qingnuan et al., 2002), multiwall 
carbon nanotubes (Guo et al., 2007) and CuS nanoparticles (Zhou et al., 2010). 
Radiolabeled nanoparticles conjugated to target specific molecules can be directly used as 
agents for diagnosis. The most common radionuclides for SPECT imaging include 99mTc 
(t1/2= 6 h) and 111In (t1/2=2.8 days), and the most common for PET are 64Cu (t1/2 =12.7 h), 18F 
(t1/2=109.8 min) and 68Ga (t1/2= 68.1 min). Moreover, radiolabeling is used to study the 
biokinetics of new devices based on nanoparticles that comprise radiopharmaceuticals, 
drug/gene delivery systems or plasmonic photothermal therapy enhancers. Many types of 
radiolabeled nanoparticles have three main components: the core, the targeting biomolecule 
and the radiotracer group (Fig. 1). The targeting biomolecule includes a component with 
high affinity for target epitopes; radiolabeling can be performed with or without slight 
modifications of the original nanoparticle (NP) surface. For ligands to bind effectively, each 
radionuclide can be conjugated directly on the NP surface, with or without a spacer, or can 
be attached to the NP during chemical synthesis. The spacer groups between the NP surface 
and the radionuclide or the biomolecule can be a simple hydrocarbon chain, a peptide 
sequence or a poly-ethyleneglycol linker. 
 
Fig. 1. Schematic structure of a radiolabeled nanoparticle design for molecular imaging 
3. Radiolabeled nanoparticles for SPECT molecular imaging 
Peptide receptors are proteins that are overexpressed in numerous human cancer cells. 
These receptors have been used as molecular targets, allowing radiolabeled peptides to 
identify tumors. The gastrin-releasing peptide receptor (GRP-r) is overexpressed in prostate 
and breast cancer, and 99mTc-Lys3-bombesin has been reported as a radiopharmaceutical with 
specific binding to cells expressing GRP-r (Ferro-Flores et al., 2006; Santos-Cuevas et al., 2008). 
Integrin ǂVǃ3 plays a critical role in tumor angiogenesis, and radiolabeled cyclic-Arg-Gly-Asp 
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(RGD) peptides have been used for noninvasive imaging of tumor ǂVǃ3 expression (Liu, 2008, 
2009). Mannosylated macromolecules labeled with 99mTc have displayed properties suitable for 
use in sentinel lymph node detection; these radiopharmaceuticals are considered target-
specific because they exhibit specific binding to mannose receptors that are expressed on 
lymph node macrophages (Vera et al., 2001; Takagi et al., 2004). 
Based on the observations above, 99mTc-labeled gold nanoparticles conjugated to Lys3-
bombesin, RGD peptides or thiol-mannose have been prepared as multimeric systems 
showing properties suitable for use as target-specific agents for molecular imaging of GRP 
receptor-positive tumors, tumor ǂVǃ3 expression and sentinel lymph node detection, 
respectively. 99mTc- and 111In-labeled carbon nanotubes, 125I-labeled silver nanoparticles and 
99mTc-labeled iron oxide nanoparticles have also been reported for SPECT imaging (Table 1). 
The strategies of synthesis and functionalization for these nanoparticles are discussed in the 
following sections. 
3.1 Synthesis of NP cores 
The most common nanomaterials reported for SPECT imaging are iron oxide NPs, gold 
NPs, silver NPs and carbon nanotubes. NPs usually have optical or magnetic properties that 
can be used for molecular imaging, whereas polymer- or liposome-based NPs do not 
produce imaging signals by themselves.  
NP core synthesis generally follows standardized strategies; for example, the most popular 
method of synthesis for gold nanoparticles (AuNPs) is based on the use of HAuCl4 (Au III) 
salt, which is reduced to metallic Au(0) in aqueous solution and stabilized with a chemical 
agent. The classical sodium citrate reduction is the oldest and most widely used method 
(Daniel & Astruc, 2004), but there are different techniques to produce AuNPs with different 
sizes and shapes using reduction agents stronger than citrate (such as NaBH4), different 
organic solvents and/or different stabilizer surfactants. Most of the stabilizer surfactants are 
quaternary ammonium salts, such as cetyltrimethylammonium bromide (CTAB), 
didodecyldimethylammonium bromide (DDAB) and tetradodecylammonium bromide 
(TTAB). Anionic surfactant syntheses have also been reported (Zhang et al., 2006). 
Anisometric gold colloids (rods) can be prepared by adding gold nuclei to HAuCl4 growth 
solutions (formed by reduction of HAuCl4 with phosphorus), and the growth of the gold 
nanorods is initiate with the addition of H2O2 (Huang et al., 2009). Electrochemical and 
photochemical reduction, microwave, ultrasound and laser ablation have also been used for 
AuNP synthesis (Ferro-Flores et al., 2010b; Huang et al., 2009). The Au(0) core is essentially 
inert and non-toxic (Connor et al., 2005). AuNPs exhibit narrow and intense absorption and 
scattering bands due to the phenomenon of plasmon resonance. This occurs at the resonance 
condition of the collective oscillation that the conduction electrons experience in an 
electromagnetic field of the appropriate wavelength. The plasmon resonance band for 
ordinary 20 nm gold nanospheres is at 520 nm, in the middle of the visible spectrum, but 
this can be red-shifted into the NIR spectrum. Rod-shaped NPs exhibit two plasmon 
resonance bands due to oscillation of the conduction electrons along the short axis and the 
long axis of the particles. The former plasmon band is called the transverse resonance and 
the latter the longitudinal resonance. While the transverse plasmon band occurs in the 
neighborhood of 520 nm, the longitudinal band is red-shifted between 675–850 nm in the 
interest of optical imaging. This occupies the most important part of the “optical imaging 
window” where light penetration in tissue is high due to reduced scattering and absorption 
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coefficients. Optical imaging techniques that rely on scattering and/or absorption contrast 
to detect pathological tissue could benefit from the use of gold nanoparticles with targeting 
capability (Huang et al., 2009). 
 
Core Surface molecule/ 
Target 
Radionuclide 
and Chelator 
Application (Reference) 
 
 
 
 
 
 
 
Gold 
nanoparticles 
 
RGD/ǂνǃ3 
integrin 
 
 
 
 
 
 
 
 
99mTc-HYNIC 
SPECT/CT imaging of ǂvǃ3 
integrin expression, and 
multimodal probe for possible 
thermotherapy  
(Morales-Avila et al., 2011) 
Lys3-Bombesin/ 
Gastrin releasing 
peptide receptors 
SPECT/CT imaging of gastrin 
releasing peptide-receptor in 
breast and prostate cancer 
detection , and multimodal 
probe for possible 
thermotherapy (Mendoza-
Sanchez et al., 2010) 
Mannose/ 
Mannose 
receptors 
SPECT/CT imaging for 
mannose receptors in sentinel 
lymph node detection in 
breast cancer, and multimodal 
probe for possible 
thermotherapy (Ocampo-
Garcia et al., 2011a, 2011b) 
-- 
 
99mTc-DTPA 
PEG-coated AuNPs for drug 
delivery vehicles and 
diagnostic imaging agents 
(Zhang et al., 2009) 
Carbon 
nanotubes 
 
-- 
99mTc-C60(OH)x 
111In-DTPA 
SPECT/CT image and 
platform for delivery of 
biologic, radiologic and 
chemical cargo to target 
tissues. (Qingnuan et al., 2002; 
Guo et al., 2007; Chan et al., 
2004; Singh et al., 2006; 
McDevitt et al., 2007) 
Rituximab  
(anti-CD20)/ 
CD20 epitope on 
human non 
Hodgkin 
lymphoma cells 
111In-DOTA 
Silver 
nanoparticles 
Poly 
(N-vinyl-2-
pyrrolidone) 
125I 
In vivo imaging and 
biodistribution of  
radiolabeled NPs  
(Chrastina & Schnitzer, 2010 ) 
Supermagnetic 
Iron oxide, 
SPIO 
Alendronate/ 
osteoclastic 
surface 
99mTc-DTPA 
Platform for SPECT/MRI 
images (Torres et al., 2011) 
Table 1. Radiolabeled nanoparticles for SPECT imaging 
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Iron oxide NPs can be synthesized via the coprecipitation of Fe2+ and Fe3+ aqueous salt 
solutions, which results in the addition of a base. The size, shape and composition of NPs 
depend on a number of factors, including: the type of salts used (e.g., chlorides, sulfates, 
nitrates or perchlorates), the Fe2+ and Fe3+ ratio, pH and ionic strength of the media. A 
variety of other methods, based on the principle of precipitation in highly constrained 
domains, have been developed and these include sol–gel preparation, polymer matrix-
mediated synthesis and precipitation using microemulsions and vesicles (Kogan et al., 2007). 
Silver nanoparticles can be synthesized in large quantities by reducing silver nitrate with 
ethylene glycol in the presence of poly(vinyl pyrrolidone) (PVP). The presence of PVP and 
its molar ratio relative to silver nitrate is important in determining the geometric shape and 
size of the product. The size, shape, and structure of metal nanoparticles are important 
because there is a strong correlation between these parameters and optical, electrical, and 
catalytic AgNP properties (Sun & Xia, 2002).  
Carbon nanotubes (CNT) are essentially hexagonal networks of carbon atoms arranged like 
a layer of graphite rolled into a cylinder consisting of pure carbon units, the C60 fullerene. 
Methods such as electric arc discharge, laser vaporization and chemical vapor deposition 
techniques are well known to produce a wide variety of single- (SWNT) and multi-walled 
(MWNT) CNTs. Catalytic chemical vapor deposition is the most commonly used, whereas 
the water-assisted synthesis method for NTs produces highly organized intrinsic nanotube 
structures. The water-stimulated synthesis enhances catalytic activity resulting in massive 
growth of super-dense and vertically aligned nanotubes (Hata et al., 2004). SWNTs produce 
high optical absorbance in the NIR (Kam et al., 2005). It has been well documented that 
water-solubilized nanotubes with high hydrophilicity are non-toxic, even at high 
concentrations (Dumortier et al., 2006). 
3.2 Preparation of radiolabeled NP-conjugates 
To achieve recognition of the molecular target, specific biomolecules are used as ligands and 
these are conjugated to the AuNP surface. These ligands include sugars, antibodies, nucleic 
acids, proteins and peptides. All of these biomolecules must offer low nonspecific binding, 
high affinity to their binding sites, no immunogenicity, fast accumulation at the target, fast 
blood clearance, and preferably exhibit no peripheral metabolic activity or toxicity. The 
biomolecules are frequently attached to the surface of the nanoparticle via electrostatic 
interactions; however, a covalent bond is preferred to prevent release of the attached 
biomolecules in vivo. The chemical bond occurs between the AuNP surface and the peptide 
containing sulfhydryl (–SH) groups (usually from cysteine) with high affinity toward the 
gold atoms. The -SH group forms a ‘staple motif’ chemical model comprised of two thiol 
groups interacting with three gold atoms in a bridge conformation (Jadzinsky et al., 2009).  
Two main strategies for binding peptides to AuNPs are commonly used. The first is the 
direct conjugation of the peptide by means of a terminal thiol (cysteine) or an N-terminal 
primary amine (Levy et al., 2004; Porta et al., 2007), and the second is an indirect conjugation 
with a linker that contains both a thiol group (that binds the nanoparticle) and a carbonyl 
terminal group, that is activated and conjugated to biological active peptides using the 
carbodiimide-coupling chemistry (Wang et al., 2005; Cheung et al., 2009). An advantage of 
the direct conjugation strategy is that it does not require the use of linkers with long chains 
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as spacers between the NP and the conjugated peptides. This is important because the 
introduction of spacers and an increase in linker length has been proven to significantly alter 
the peptide-multivalency effect, which may correlate to a decrease in the effective peptide 
molarity (Kubas et al., 2010).  
Current methodologies for SPECT molecular imaging require an additional ligand that is 
appended to the AuNP surface, and this ligand functions as a chelator of the radiometal. 
Two different kinds of molecules can be bound to the AuNP surface to produce hybrid 
radiolabeled AuNP-peptide systems. In our research, we have reported two different 
radionuclide chelators to generate radiolabeled gold nanoparticles. Mendoza-Sanchez et al., 
(2010), Ocampo-Garcia et al., (2011b) and Morales-Avila et al., (2011) demonstrated 
radiolabeling of AuNPs using 6-hydrazinopyridine-3-carboxylic(HYNIC)-GGC peptide. 
With this approach, HYNIC was added as a 99mTc chelator group, -Gly-Gly- as a spacer 
group and -Cys as the active group that interacted with the nanoparticle surface (Fig. 2). In 
the second approach, the HYNIC-Tyr3-Octreotide (HYNIC-TOC) was used for AuNP 
radiolabeling, whereby the HYNIC group was the 99mTc chelator and the cysteine contained 
in the disulphide bridge or the ε-amine of lysine was the reactive group for AuNP 
conjugation (Ocampo-Garcia et al., 2011a) (Fig. 3). 
 
Fig. 2. Radiolabeling of gold nanoparticles conjugated to biomolecules using HYNIC-GGG 
as 99mTc chelator: a) radiolabeling after biomolecule conjugation to AuNP and b) conjugation 
and radiolabeling in a single step without further purification. 
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Mendoza-Sanchez et al., (2010) and Ocampo-Garcia et al., (2011b) conjugated peptides to the 
gold nanoparticle surface using a posterior radiolabeling process. This process was 
conducted by adding ethylenediaminediacetic acid (EDDA)/Tricine, SnCl2 (as reducing 
agent) and 99mTc-pertechnetate to 1 mL of HYNIC-GGC-AuNP followed by incubation at 
100 °C for 20 min. The mixture was purified by size-exclusion chromatography (PD-10 
column, Sephadex G-25) using injectable grade water as the eluent by collecting 0.5 mL 
fractions. The first peak (3.0–4.0 mL) corresponded to the void volume of the column and 
contained 99mTc-EDDA/HYNIC-GGC-AuNP (a radioactive red color solution), while the 
second peak corresponded to 99mTc-EDDA (6.0–8.0 mL). Free 99mTcO4– and 99mTc-colloid 
remained in the PD-10 column (Fig. 2a). In a second approach (Morales-Avila et al., 2011), 
the peptide conjugation to AuNPs and the radiolabeling were carried out in a single step 
without further purification (Fig. 2b). 
 
Fig. 3. Radiolabeling of gold nanoparticles conjugated to biomolecules using HYNIC-TOC as 
99mTc chelator . 
Zhang et al. (2009) obtained 111In-labeled polyethylene-glycol (PEG)-AuNPs using 
diethylenetriaminepentaacetic acid–thioctic acid (DTPA-TA) as radiometal chelator. They 
found a strong dependency between pharmacokinetics/biodistribution and the size and 
density of PEG coating on the AuNP surface.  
Chan et al. (2004) prepared carbon-encapsulated 99mTc nanoparticles. Fullerenes can be 
directly labeled with 99mTc using ascorbic acid/SnCl2 as reducing agents to form 
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99mTc-C60(OH)X, however, biodistribution studies indicated that the radionanoparticles were 
distributed in all tissues (Qingnuan et al., 2002). The 99mTc-glucosamine-MWNT, also labeled 
by the direct method, is water-soluble, and further modification of this system may allow 
the development of a versatile delivery system for molecular targeting (Guo et al., 2007).  
111In-labeled carbon nanotubes were synthesized by Singh et al. (2006). The ammonium-
functionalized CNTs (single- and multi-walled) were prepared following the 1,3-dipolar 
cycle addition method to be covalently bound to DTPA. Biodistribution studies showed a 
rapid blood clearance (half-life=3 h) with renal excretion. Radiolabeling of CNTs with 111In 
has also been reported by McDevitt et al., 2007. In general, CNTs are functionalized with 2-
(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic (DOTA-NCS) 
via thiolurea bonding and radiolabeled by adding 111In chloride to the DOTA-CNT 
conjugate.  
Chrastina & Schnitzer (2010) reported the synthesis of silver nanoparticles labeled with 
iodine-125 to track in vivo tissue targeting with SPECT images. Poly(N-vinyl-2-pyrrolidone)-
capped silver nanoparticles (average size 12 nm) were labeled by chemisorptions, whereby 
chloramine-T (N-chlorobenzenesulfonamide) was immobilized on a polystyrene backbone. 
The radio-solution was removed and added to a dispersion of unfunctionalized Ag 
nanoparticles. Unbound iodide-125 was removed by size exclusion chromatography on 
Sephadex G-25 columns. Radiochemical yields higher than 95% were obtained. 
Radiolabeled AgNPs were characterized by UV-Vis spectrometry (410 nm). 
Torres et al., (2011) reported the development of a new class of dual-modality imaging 
agents based on the conjugation of radiolabeled bisphosphonates (BP) directly to the surface 
of superparamagnetic iron oxide (SPIO) nanoparticles (5 nm, FeΎOΏ core). The SPIO labeling 
with 99mTc-DTPA-alendronate was performed in a single step at room temperature. The 
radiolabeled nanoparticles showed excellent stability, making the conjugate suitable for 
SPECT-CT/MRI imaging. 
3.3 Structural, chemical and radiochemical characterization  
Several methods have been used for the structural characterization of nanoparticles, 
including X-ray diffraction (XRD), small-angle X-ray scattering (SAXS), microscopic 
techniques such as scanning electron microscopy (SEM), high-resolution transmission 
microscopy (HRTEM) and scanning probe microscopy (SPM). For the chemical 
characterization of the biomolecule-nanoparticle conjugate, spectroscopic methods have 
been applied to confirm the chemical interaction and functionalization of NPs with the 
biomolecules. These methods include UV-Vis, infrared, Raman, fluorescence and XPS 
spectroscopy. For example, in the case of peptides conjugated to AuNPs, the vibrational 
spectroscopic techniques can be used to confirm that the biomolecule displaces the 
carboxylate groups of the citrate on the AuNP surface. The structured spectra can be used to 
confirm that AuNPs were functionalized with peptides, because several well defined bands 
with vibrational frequencies in the region of those associated with the main functional 
groups of the peptides can be observed in the AuNP-peptide conjugate, even though these 
will have characteristics of the AuNP-peptide because the bands shift to lower or higher 
energies and increase in intensities (Surujpaul et al., 2008; Morales-Avila et al., 2011). 
Additionally, the Au-S bond shows a characteristic band at 279 ± 1 cm-1 identified by far-
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infrared spectroscopy (Ocampo-Garcia et al., 2011a). In UV-Vis spectroscopy a red shift in 
the maximum absorbance of the AuNP is representative of the peptide conjugation process, 
while the small change in the surface plasmon resonance position occurs as the result of the 
peptide adsorption on the AuNP surface (Kogan et al., 2007; Ferro-Flores et al. 2010b). The 
orbital energies of Au-Au or AuNP (Au0) and Au-S (Au+1) bonds are related to changes in 
the oxidative states (Au0 to Au+1); therefore, in XPS analyses the shift of electron binding 
energies to higher values in the AuNP-peptide conjugates, with respect to AuNPs, is an 
intrinsic property of the interaction between gold core electrons and the peptide (Mendoza-
Sanchez et al., 2010; Ocampo-Garcia et al., 2011b).  
The methods frequently used to determine radiochemical purity and assess quality control 
of the radiolabelled nanoparticles include instant thin layer chromatography (ITLC), which 
has the advantage of being very quick and easy to use, and size-exclusion high performance 
liquid chromatography (SE-HPLC) that can be used as an accurate method depending on 
the NPs size. PD-10 columns and ultrafiltration can be used as easy purification methods 
and to determine radiochemical purity (Ocampo-Garcia et al., 2011a).  
3.4 Biological recognition  
It has been demonstrated that multimeric systems of 99mTc-AuNP-biomolecules exhibit 
properties that make them suitable for use as target-specific agents for molecular imaging of 
tumors and sentinel lymph node detection. For example, in vitro binding studies of 
99mTc-AuNP-RGD conducted in ǂVǃ3 receptor positive C6 glioma cancer cells showed 
specific recognition for those receptors (Morales-Avila et. al., 2011). Moreover, 99mTc-AuNP-
Lys3-bombesin showed specific recognitions for GRP receptors in PC3 cancer cells 
(Mendoza-Sanchez, et al., 2010) and 99mTc-AuNP-mannose demonstrated specificity for 
mannose receptors (Ocampo-Garcia et al., 2011a). Micro-SPECT/CT images of these 
radiopharmaceuticals have shown a clear tumor uptake or lymph node accumulation 
(Fig. 4). 
      
 
99mTc-AuNP-Mannose 99mTc-AuNP-RGD 99mTc-AuNP-Lys3-bombesin 
 
Fig. 4. Micro-SPECT/CT images of 99mTc-labeled gold nanoparticles in mice with induced 
tumors (conjugates of Lys3-bombesin and RGD) and in Wistar rat (mannose conjugate). 
The 111In-DTPA-TA-AuNP-PEG system has shown a prolonged blood circulation and 
significant tumor uptake by the enhanced permeability and retention effect, making of the 
radiolabeled AuNPs a promising drug delivery vehicle and diagnostic imaging agent 
(Zhang et al., 2009). 
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The multifunctional system of carbon nanotubes, conjugated to both anti-CD20 (Rituximab) 
and 111In-DOTA-NCS, demonstrated ability of this double conjugate to specifically target 
tumor cells in vitro (in CD20+ specific Daudi cells) and tumors in vivo using a murine model 
of disseminated Lymphoma (McDevitt et al. 2007). 
4. Radiolabeled nanoparticles for PET molecular imaging 
PET is a nuclear imaging technique used to map biological and physiological processes in 
living subjects following the administration of radiolabeled probes. In PET, the radionuclide 
decays and the resulting positrons subsequently interact with nearby electrons after 
travelling a short distance (~1 mm) within the body. Each positron-electron transmutation 
produces two 511-keV gamma photons in opposite trajectories, and these two gamma 
photons may be detected by the detectors surrounding the subject to precisely locate the 
source of the decay event. Subsequently, the “coincidence events” data can be processed by 
computers to reconstruct the spatial distribution of the radiotracer (Chen & Conti, 2011). 
Several positron-emitting radionuclides have been used in the development of radiolabeled 
nanoparticles. These radionuclides include 64Cu (Emax 657 keV), 18F (Emax 635 keV) and 68Ga 
(Emax 1.90 MeV), which are described in the following sections. 
4.1 64Cu-labeled nanoparticles 
The 64Cu radionuclide can be effectively produced using both reactor- and accelerator-based 
methods. Its use as a positron emitter has grown, and it has been reported to be suitable for 
the radiolabeling of proteins, antibodies and peptides. In addition, 64Cu has been 
investigated as a promising radiotracer for real-time PET monitoring of regional drug 
concentration and for pharmacokinetics applications. Its integration as a structural 
component of nanoparticles produces multimeric systems suitable for therapy and PET 
imaging (Zhou et al., 2010).  
To date, nanocrystals (quantum dot), iron oxide nanoparticles, SWNT and gold 
nanoparticles (nanoshells) have been functionalized with 64Cu ligands for PET/MRI or 
PET/NIR fluorescence imaging and therapy. In these multiple combinations, the same 
molecular target can be evaluated with two different imaging modalities. These groupings 
allow the strengths of each to improve the overall diagnostic accuracy, and this approach 
provides a synergistic effect, increasing expectations for high sensitive and high-resolution 
imaging (Hong, 2009). 
Quantum dots (QDs) or nanocrystals are fluorescent semiconductor nanoparticles (2-10 nm) 
with many unique optical properties including bright fluorescence, resistance to 
photobleaching, and a narrow emission bandwidth (Ferro-Flores et al., 2010a). Their 
fluorescence emission wavelength can be continuously tuned from 400 nm to 2000 nm by 
changing both the particle size and chemical composition. Their quantum yields are as high 
as 85 %. The particles are generally made from hundreds to thousands of atoms (~200-10,000 
atoms) of IIB and VIA family elements (e.g. CdSe and CdTe) or IIIA and VA family elements 
(e.g. InP and InAs). Recent advances have allowed the precise control of particle size, shape 
and internal structure (core-shell, gradient alloy or homogenous alloy) (Yu et al., 2003). As 
cadmium is potentially toxic, Gao et al. (2004) developed a class of QD conjugates that 
contains an amphiphilic triblock copolymer for in vivo protection and multiple PEG 
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molecules for improving biocompatibility and circulation. InAs/InP/ZnSe Core/Shell/Shell 
quantum dots without Cd have significantly lower intrinsic toxicity compared to QDs 
containing elements such as cadmium (Xie et al., 2008). 
A dual-modality PET/NIR fluorescent peptide has been recently reported (Cai et al., 2007; 
Chen et al., 2010). A QD (QD705; emission maximum, 705 nm) with an amine-functionalized 
surface was modified with RGD (90 peptides per QD) or the vascular endothelial growth 
factor (VEGF) and 1,4,7,10-tetraazacyclodocecane-N,N',N'',N'''-tetraacetic acid (DOTA) 
chelator for integrin-ǂvǃ3 or VEGF imaging. PET/NIR imaging, tissue homogenate 
fluorescence measurement, and immunofluorescence staining were performed with U87MG 
human glioblastoma tumor-bearing mice to quantify the 64Cu-DOTA-QD-RGD and 64Cu-
DOTA-QD-VEGF uptake in tumor and major organs. Excellent linear correlation was 
obtained between the results measured by in vivo PET imaging and those measured by ex 
vivo NIR fluorescent imaging and tissue homogenate fluorescence. Histologic examination 
revealed that 64Cu-DOTA-QD-RGD targets primarily the tumor vasculature through a RGD-
integrin interaction, with little extravasation. The authors concluded that this dual-function 
probe has significantly reduced potential toxicity and overcomes the tissue penetration 
limitation of optical imaging, requisite for quantitative targeted imaging in deep tissue.  
Iron oxide nanoparticles have magnetic properties and have been extensively investigated 
for biomedical applications due to their excellent biocompatibility and ease of synthesis. 
Jarrett et al. (2008) recently reported a dual-mode imaging probe for PET/MRI that was 
designed for vascular inflammation, and this probe was based on iron oxide nanoparticles 
coupled to 64Cu. The labeling of SPIONs was made by coordination of 64Cu to the chelating 
bifunctional ligand S-2-(4- isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetic acid (p-SCNBz-DOTA) and followed by conjugation to the nanoparticle. For the 
dextran sulfate coated nanoparticles, the particle surface was modified to contain aldehyde 
groups that can be conjugated to the amine-reactive p-SCN-Bz-DOTA chelator. Xie et al. 
(2010) encapsulated iron oxide nanoparticles (IONPs) into human serum albumin (HSA) 
matrices. The HSA coated IONPs (HSA-IONPs) were dually labeled with 64Cu-DOTA and 
Cy5.5, and tested in a subcutaneous U87MG xenograft mouse model. In vivo PET/NIR 
fluorescence/MRI tri-modality imaging showed massive accumulation in lesions, high 
extravasation rate, and low uptake of the particles by macrophages at the tumor area. Glaus 
et al. (2010) prepared 64Cu-DOTA-PEG-SPIOs which demonstrated strong MR and PET 
signals and high stability in mouse serum for 24 h at 37 °C. 
To image Vǃ3 expression, multifunctional 64Cu-labeled IONPs conjugated to RGD have 
been reported. Lee et al. (2008) developed the 64Cu-DOTA-IO-RGD system (diameter: 45 ± 
10 nm) containing 35 RGD peptide molecules and 30 DOTA chelating units per 
nanoparticle. The receptor-binding affinity studies for vǃ3 integrin in U87MG cells showed 
an IC50 value of 34 ± 5 nM. cRGDfC and the macrocyclic 1,4,7-triazacyclononane-N,N’,N’’-
triacetic-thiol derivative (NOTA-SH) were conjugated onto the iron oxide nanoparticles. 
64Cu-labeled SPIONs conjugated to cRGDfC demonstrated a good U87MG tumor-targeting 
capability and tumor contrast by PET/MRI dual-modality imaging (Yang et al., 2011).  
Liu et al. (2007) investigated the biodistribution of 64Cu-labeled SWNTs conjugated to 
polyethylene-glycol-DOTA and RGD in mice with U87MG-induced tumors using PET, ex 
vivo biodistribution and Raman spectroscopy. The results showed a high 64Cu-DOTA-PEG-
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SWNT-RGD tumor accumulation (∼7% at 1 h) that was attributed to the multivalent effect 
of the SWNTs. 
Gold nanoshells (NSs) are core/shell particles comprised of a gold shell and a dielectric 
silica core with peak plasmon resonances tunable to desired wavelengths by adjusting the 
relative core and shell thicknesses. At NIR wavelengths, light penetrates up to several 
centimeters in tissue. NSs absorb in the NIR wavelength and efficiently convert incident 
light to heat (eg, a 120-nm core diameter and a 14-nm-thick shell result in an absorption 
peak between 780 nm and 800 nm). Xie et al. (2011) reported the preparation of 64Cu-DOTA 
labeled NSs conjugated to cRGDfK and evaluated the in vivo biodistribution and tumor 
specificity of these in live nude rats bearing head and neck squamous cell carcinoma 
(HNSCC) xenografts. The potential therapeutic properties were also evaluated by 
subablative thermal therapy of tumors. PET/CT imaging showed a high tumor uptake even 
at ~20 h postinjection and the thermal therapy study showed a high degree of tumor 
necrosis. 
 
Core 
Surface 
molecule/Target 
64Cu 
Chelator 
Imaging 
Modality 
Reference 
Quantum Dots 
 
RGD/vǃ3  
integrin or 
VEGF/VEGF-r 
DOTA 
PET/NIR 
fluorescence 
Cai et al., 
2007; Chen et 
al., 2010 
Iron oxide 
nanoparticles 
 
RGD/vǃ3 integrin 
DOTA and p-
SCN-Bz-
DOTA PET/MRI 
Lee et al., 
2008; Jarret et 
al., 2008 
NOTA-SH 
Yang et al., 
2011 
PEGylated 
phospholipids 
DOTA PET/MRI 
Glaus et al., 
2010 
Human serum 
albumin and Cy5.5 
DOTA 
PET/MRI/ 
NIR 
fluorescence 
Xie et al., 
2010 
Carbon nanotubes 
 
RGD/vǃ3 integrin PEG-DOTA PET/NIR fluorescence 
Liu et al., 
2007 
Gold nanoshells 
 
RGD/vǃ3 integrin DOTA 
PET/CT 
imaging and 
thermotherapy 
Hie et al., 
2011 
Table 2. 64Cu-labeled nanoparticles for PET imaging 
4.2 18F labeled iron oxide nanoparticles for PET/MRI 
The main requirement for MRI is the efficient capture of magnetic nanoparticles by the cell, 
and when a cell is sufficiently loaded with magnetic material, MRI can also be used for cell 
tracking. The synthesis and in vivo characterization of iron oxide nanoparticles labeled with 
18F was reported by Devaraj et al. (2009). This particle consists of cross-linked dextran 
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molecules held together in core-shell formation by a superparamagnetic iron oxide core and 
functionalized with the radionuclide 18F in high yield, via “click” chemistry. Such 
nanoparticles could accurately detect lymph nodes (LNs), which are critical for assessing 
cancer metastasis. In vivo PET/MRI images could clearly identify small (~1 mm) LNs along 
with precise anatomical information. 
4.3 68Ga labeled nanoparticles  
Stelter et al. (2009) covalently bound the transfection agent HIV-1 Tat (peptide derived from 
the transcription protein transactivator of the human immunodeficiency virus), the 
fluorescent dye fluorescein isothiocyanate and 68Ga to the aminosilane-coated 
superparamagnetic nanoparticle. PET imaging and MRI revealed increasing hepatic and 
splenic accumulation of the particles over 24 h in Wistar rats. Hepatogenic HuH7 cells were 
labeled with the radionanoparticles and injected them intravenously into rats, followed by 
animal PET and MRI imaging. In vitro studies in hepatogenic HuH7 cells showed a rapid 
intracellular accumulation of the labeled nanoparticles and without any signs of toxicity. In 
vivo dissemination of the labeled cells was followed by dynamic biodistribution studies. 
This radionanoconjugate can be applicable to efficient cell labeling and subsequent 
multimodal molecular imaging. Moreover, their multiple free amino groups suggest the 
possibility of further modifications and might provide interesting opportunities for various 
research fields. 
A quadruple imaging modality made using nanoparticles that is capable of concurrent 
fluorescence, bioluminescence, bioluminescence resonance energy transfer (BRET), PET and 
MRI has been reported (Hwang et al., 2009). A cobalt–ferrite nanoparticle surrounded by 
rhodamine (MF) was conjugated with luciferase (MFB) and p-SCNbnNOTA (2-(4-
isothiocyanatobenzyl)-1,4,7-triazacyclonane-1,4,7-triacetic acid) followed by 68GaCl3 
(magnetic-fluorescent-bioluminescent-radioisotopic particle, MFBR). Confocal microscopy 
revealed good transfection efficiency of MFB into cells and BRET was also observed in MFB. 
A good correlation among rhodamine, luciferase, and 68GaCl3 was found in MFBR, and the 
activities of each imaging modality increased dose-dependently with the amount of MFBR 
in the C6 cells. In vivo optical images were acquired from the thighs of mice after 
intramuscular and subcutaneous injections of MFBR-laden cells. MicroPET and MR images 
showed intense radioactivity and ferromagnetic intensities with MFBR-laden cells. The 
multimodal imaging strategy could be used as a potential imaging tool to improve the 
diagnostic accuracy. 
5. Radiolabeled nanoparticle for therapy 
Radiolabeled nanoparticles represent novel agents with huge potential for clinical 
radiotherapy applications. McDevitt et al. (2010) proposed the radiolabeling of carbon 
nanotubes (DOTA-NTs, diameter of 1.4 nm.) functionalized by the anti-CD20 monoclonal 
antibody (Rituximab), the ǂ-particle emitter 225Ac and the -particle emitter 90Y. Alpha-
emitters can be efficient therapeutics against small-volume tumors and micrometastatic 
cancers due to the linear energy transfer that is 500 times greater than that of  particles; 
hence, damaged cells have inadequate capability to repair DNA injure, and cell death may 
result. Beta-particle emitters are the most widely used radionuclides among the cancer 
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therapeutic agents because the localized decay in target cells generates DNA damaging free 
radicals, which can induce apoptosis (Fig. 4). Kucka et al. (2006) have also proposed the 
astatination of silver nanoparticles conjugated to poly(ethylene oxide) as possible carriers of 
the ǂ-particle emitter 211At. 
 
Fig. 4. Schematic representation of radiolabeled nanoparticles for therapeutic applications 
The impermeable nature of the cell plasma membrane limits the therapeutic uses of many 
macromolecules. Several cell penetrating peptides, such as the HIV-1 Tat peptide, have been 
shown to traverse the cell membrane (where integral protein transduction domains (PTDs) 
are responsible for cellular uptake) and to reach the nucleus while retaining biological 
activity. PTDs can enable the cellular delivery of conjugated biomolecules and even 
nanoparticles, but nuclear delivery needs other strategies. Berry et al. (2007) developed 
biocompatible gold nanoparticles of differing sizes, functionalized with the HIV Tat-PTD, 
with the aim of producing nuclear targeting agents. The particles were subsequently tested 
in vitro on a human fibroblast cell line, and the results demonstrated successful nanoparticle 
transfer across the plasma membrane with 5 nm particles achieving nuclear entry while 
larger 30 nm particles were retained in the cytoplasm, suggesting entry was blocked via 
nuclear pores dimensions. 99mTc internalized in cancer cell nuclei acts as an effective system 
of targeted radiotherapy because of the Auger and internal conversion electron emissions 
near DNA. The HIV Tat(49-57) is a cell penetrating peptide that reaches DNA (Santos-
Cuevas et al., 2011). Therefore, 99mTc-labeled gold nanoparticles (5nm) prepared by the 
methods previously described (Ocampo-Garcia et al., 2011b; Morales-Avila et al., 2011) and 
conjugated to the HIV Tat(49-57) peptide, could potentially be a multifunctional system with 
properties suitable for targeted radionuclide therapy. 
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The -particle emitter 188Re has been conjugated to NPs for radiotherapy purposes. In 2004, 
Cao et al. prepared silica-coated magnetite nanoparticles immobilized with histidine. 188Re 
was linked on their surface by the complexation of [188Re(CO)3(H2O)3]+ to the imidazolyl 
groups of histidine, obtaining a labeling yield of 91%. A direct labeling method has also 
been reported that radiolabels SPIONs with rhenium-188 (Liang et al., 2007). The 
radiolabeling efficiency was about 90%, with good in vitro stability. 188Re labeled SPIONs 
demonstrated the ability to kill SMMC-7721 liver cancer cells.  
Photothermal ablation (PTA) therapy is a minimally invasive alternative to conventional 
approaches for cancer treatment. NPs, primarily gold nanostructures such as gold 
nanoshells, nanorods, nanocages and hollow nanospheres but also carbon nanotubes, have 
been investigated as photothermal coupling agents to enhance the efficacy of PTA therapy. 
These plasmonic nanomaterials exhibit strong absorption in the NIR region (700-1100 nm) 
and offer the opportunity to convert optical energy into thermal energy, enabling the 
deposition of otherwise benign optical energy into tumors for thermal ablation of tumor 
cells, as recently demonstrated Xie et al. (2011). Furthermore, AuNPs can be labeled with ǂ- 
or ǃ-particle emitter radionuclides and linked to target specific biomolecules to produce 
both thermotherapy and radiotheraphy effects on cancer cells.  
Zhou et al. (2010) synthesized and evaluated a novel class of chelator-free [64Cu]CuS 
nanoparticles (NPs) suitable both for PET imaging and as photothermal coupling agents for 
photothermal ablation. [64Cu]CuS NPs possess excellent stability, and allow robust 
noninvasive micro-PET imaging. The CuS NPs display strong absorption in the near-
infrared (NIR) region (peak at 930 nm); passive targeting prefers the tumor site, and 
mediated ablation of U87MG tumor cells occurs upon exposure to NIR light both in vitro 
and in vivo after either intratumoral or intravenous injection. The combination of small 
diameter (11 nm), strong NIR absorption, and integration of 64Cu as a structural component 
makes these [64Cu]CuS NPs suited for multifunctional molecular imaging and therapy. 
6. View to the future 
Looking into the future of the field of nuclear molecular imaging, we have to think about the 
development of the next generation of radiopharmaceuticals combining variety of 
properties and allowing for the simultaneous performance of multiple functions. The great 
diversity of nanoparticle cores and biomolecules that can be attached to the nanoparticle 
surface, offers the possibility of creating multifunctional devices to be used in hybrid 
imaging platforms.  
In the field of molecular therapy, some nanoparticles offer novel proposals for the delivery 
of therapeutic and target-specific drugs. Multifunctional radiolabeled nanoparticles can 
combine imaging and therapeutic agents in one preparation and specifically target the site 
of the disease (accumulate there) via both non-specific and specific mechanisms, such as the 
enhanced permeability and retention (EPR) effect for macromolecules (Maeda et al., 2000) 
and the ligand-mediated recognition.  
In all clinically relevant imaging modalities, contrast agents are used to absorb certain types 
of signal much stronger than do the surrounding tissues. To still further increase a local 
spatial concentration of a contrast agent for better imaging, it is a natural progression to use 
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nanoparticles to carry multiple contrast moieties for an efficient enhancing of the signal 
from these areas (Torchilin, 2006). 
A nanoparticle that has intrinsic imaging and therapeutic properties is advantageous. For 
gold and SWNT nanoparticles, the composition itself produces imaging contrast (optical 
imaging). Moreover, these nanoparticles have thermoablative properties. Local application 
of heat is a known concept in therapeutic medicine that has been extensively explored for 
cancer treatment and other conditions. Excitation sources, such as infrared lamps, 
ultrasound or lasers, can be used in the process, but there is always the problem of limiting 
the heat generated to just the area of the target tissue. This problem could be solved by 
using nanoparticles designed to absorb in the NIR region so that the resulting localized 
heating causes irreversible thermal cellular destruction. A laser irradiation (NIR light) of 
SWNT or gold nanoparticles leads to a rise in the temperature of the target regions from 
40°C to 50°C, which selectively could destroy a carcinoma (Pissuwan et al., 2006).  
An important benefit of receptor-specific radiopharmaceuticals is their use for targeted 
radiotherapy. Multiple specific biomolecules to target breast cancer cells, appended to one 
gold nanoparticle and labeled with an imaging radionuclide such as 99mTc as well as a 
ǃ-particle-emitting radionuclide such as 90Y, 177Lu or 188Re, could be a multifunctional 
system useful for the identification of malignant tumors (SPECT/NIR fluorescence imaging) 
and metastatic sites (avoiding immunohistochemistry studies), for targeted radiotherapy 
(high ǃ-particle-energy delivered per unit of targeted mass) and for photothermal therapy 
(localized heating). Furthermore, 99mTc internalized in cancer cell nuclei acts as an effective 
system of targeted radiotherapy because of the Auger and internal conversion electron 
emissions near DNA. 99mTc-labeled gold nanoparticles described above and also conjugated 
to the HIV Tat(49-57) peptide to reach DNA, could potentially be a radiotherapeutic system 
at cellular level. However, for therapeutic purposes NPs should be administered by 
intratumoral injection or into a selective artery to avoid a high uptake by organs of the 
reticuloendothelial system because of the NPs’ colloidal nature.  
The traditional concept of separating diagnosis and treatment could conclude. The use of 
multifunctional radiolabeled nanoparticles that can simultaneously detect, image, and treat 
diseases may one day become the first alternative instead of the exception. 
7. Conclusions 
In our research we have demonstrated that it is possible to prepare stable hybrid 
radiolabeled gold nanoparticles. Multimeric systems of 99mTc-labeled gold nanoparticles 
conjugated to peptides or mannose can be prepared from kit formulations with high 
radiochemical purities (>94%). 99mTc-AuNP-Lys3-bombesin, 99mTc-AuNP-c[RDGfK(C)] and 
99mTc-AuNP-mannose show properties suitable for use as target-specific agents for 
molecular imaging of GRP receptor-positive tumors, tumor ǂVǃ3 expression and sentinel 
lymph node detection, respectively, with the possibility to be used as photothermal 
therapeutic systems. 
Multifunctional nanoparticles can combine diagnostic and therapeutic capabilities for 
targeted-specific diagnosis and the treatment of disease. Medical imaging modalities such as 
SPECT, PET and MRI can identify tumors non-invasively, but radiolabeled nanoparticle 
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probes with multivalent properties can provide multimodal images with enhanced signal 
and sensitivity. Developments of radioactive QD-, AuNP-, SWNT-, CuS- or IO-target-
specific biomolecules can be further developed to provide a visual guide during surgery. 
Radiolabeled SWNT and gold nanoparticles have a variety of real or potential applications 
in medical diagnosis and therapeutic treatments, due to their particularly combination of 
optical and photothermal properties. However, the work in this field is still in its infancy, 
and the achievement of more in vivo preclinical and clinical trials is required. 
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